| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 10/11/1994 | USRE34756 Excretion of potassium ion by prostanoic acid derivatives |
| 10/05/1994 | EP0618224A1 Phosphonomethyldipeptides |
| 10/04/1994 | US5352708 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 09/29/1994 | WO1994021641A1 Process for production of an imidazole derivative |
| 09/29/1994 | WO1994021590A1 Phenoxyphenylacetic acid derivatives |
| 09/29/1994 | CA2155573A1 Process for production of an imidazole derivative |
| 09/28/1994 | EP0617023A1 Benzimidazole derivatives, their preparation and use |
| 09/28/1994 | EP0617010A1 Therapeutic compounds |
| 09/28/1994 | EP0617001A1 Phenoxyphenylacetic acid derivatives |
| 09/28/1994 | EP0616536A1 INHIBITING TRANSFORMING GROWTH FACTOR $g(b) TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
| 09/27/1994 | US5350757 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin II receptor antagonist properties |
| 09/21/1994 | EP0440688B1 Cpf peptide compositions and uses |
| 09/21/1994 | CN1092428A Conception promoting 19, 11beta-overbrige 4-estratrene |
| 09/21/1994 | CN1092412A Alkylenediamine derivatives |
| 09/20/1994 | CA2119051A1 Phenoxyphenylacetic acid derivatives |
| 09/16/1994 | CA2118821A1 Therapeutic compounds |
| 09/15/1994 | WO1994020637A1 Fertility regulation with transforming growth factor beta |
| 09/15/1994 | WO1994020532A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 09/15/1994 | WO1994020491A1 Benzopyranes as potassium channel openers |
| 09/15/1994 | WO1994020483A1 Process to derivatives of piperizinylcamphorsulfonyl oxytocin antagonists |
| 09/15/1994 | WO1994020478A1 Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions |
| 09/15/1994 | WO1994020128A1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 09/15/1994 | WO1994020083A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
| 09/15/1994 | WO1994011394A3 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 09/15/1994 | CA2157865A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
| 09/15/1994 | CA2156613A1 Fertility regulation with transforming growth factor beta |
| 09/14/1994 | EP0614975A1 Glycoprotein hormone receptor molecules |
| 09/14/1994 | EP0614894A1 Process for the synthesis of substituted amide derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
| 09/14/1994 | EP0614369A1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 09/14/1994 | EP0614365A1 Use of a known chemical compound for the production of a pharmaceutical composition for topical application |
| 09/13/1994 | US5347011 Substituted triazoles as angiotensin II inhibitors |
| 09/13/1994 | CA2118756A1 Process for the synthesis of substituted amide derivatives of piperizinylcamphorsulfonyl oxytocin antagonists |
| 09/07/1994 | EP0613686A1 Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants |
| 09/07/1994 | EP0613472A1 10-acyl-dibenz(b,f) (1,4)-oxazepines and their thiazepines analo gues useful as prostaglandin antagonists |
| 09/07/1994 | EP0613465A1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
| 09/07/1994 | EP0613375A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 09/07/1994 | EP0613374A1 Lactobacillus and skim milk compositions and methods for preventing microbial urogenital infections |
| 09/07/1994 | EP0478609B1 Srif-related peptides and uses thereof |
| 09/06/1994 | US5344835 Piperidine and pyrrolidine derivatives |
| 09/06/1994 | US5344826 Tricycle steroid analogs |
| 09/01/1994 | WO1994019354A1 Chemical compounds |
| 09/01/1994 | CA2156186A1 Chemical compounds |
| 08/31/1994 | EP0612723A1 Substituted benzoylguanidines, process for their preparation, their use as medicament, as inhibitor of the cellular Na+/H+ exchange or as diagnostic agent and medicament containing them |
| 08/31/1994 | EP0612530A2 Pharmaceutical preparations containing tumor cytotoxic factor |
| 08/31/1994 | EP0612244A1 Endothelin receptor antagonists |
| 08/31/1994 | EP0612216A1 Phospholipid antimicrobial compositions |
| 08/31/1994 | EP0408691B1 Antinephrotoxic perfusion solution |
| 08/30/1994 | US5342948 Antiandrogens; ozonation, amination, reduction of androstane derivative with acyl(urea or thiourea) |
| 08/24/1994 | EP0611765A1 2-(Imidazol-1-yl)-3-heteroarylpropylidene-aminoxyalkanoic acid derivatives |
| 08/24/1994 | EP0611755A1 (Cyclohexyl)-alken compounds, process for their preparation and pharmaceutical compositions containing them |
| 08/24/1994 | EP0611572A2 Process to prepare a cetrorelix lyophilised composition |
| 08/24/1994 | CN1091129A Excitatory amino acid receptor antagonists |
| 08/23/1994 | US5340819 Method for treating urinary incontinence using 9-(3-nitrophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2H,5H) acridinedione |
| 08/23/1994 | US5340813 Substituted aminoalkyl xanthine compounds |
| 08/21/1994 | CA2115967A1 Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical, as inhibitors of the cellular na+/h+exchange or as a diagnostic, and pharmaceutical containing them |
| 08/18/1994 | WO1994018323A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 08/18/1994 | WO1994018168A1 Indole derivatives as 5-alpha-reductase inhibitors |
| 08/17/1994 | EP0610943A1 Pyridinium derivatives useful as PAF antagonists |
| 08/17/1994 | EP0610697A1 Imidazole substituted phenylaceticacidprolinzamide derivatives |
| 08/17/1994 | EP0610451A1 Ethynyl alanine amino diol compounds for treatment of hypertension |
| 08/17/1994 | CN1090776A Method for the safe administration of fatty acids |
| 08/17/1994 | CN1090757A Method for the safe administration of fatty acids |
| 08/17/1994 | CA2115718A1 Novel cyclohexyl alkene compounds, processes for their preparation and pharmaceutical compositions containing them |
| 08/16/1994 | US5338756 Benzimidazole compounds |
| 08/16/1994 | US5338744 Angiotensin II antagonists used to treat reproductive functions associated with AT2 receptors |
| 08/16/1994 | US5338726 Endothelin converting enzyme inhibitors |
| 08/16/1994 | CA1331459C Sulfonyldecahydro-8h-isoquino-¬2,1-g|¬1,6|- naphthyridines, optical isomers thereof and related compounds |
| 08/12/1994 | CA2114183A1 Pyridinium derivatives |
| 08/10/1994 | EP0609345A1 Biocompatible implant for the timing of ovulation in mares |
| 08/10/1994 | EP0609217A1 Dry starch-iodine pharmaceutical formulations |
| 08/10/1994 | CN1090490A Fatty acid treatment |
| 08/09/1994 | US5336686 17 Methylene lactones of steroids |
| 08/09/1994 | US5336678 Topical administration |
| 08/04/1994 | WO1994016728A1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants |
| 08/04/1994 | WO1994009785A3 Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis |
| 08/04/1994 | CA2154278A1 Anti-lfa-1 monoclonal antibodies used for the preparation of a medecine prenventing the rejection of grafted organs |
| 08/03/1994 | EP0608709A1 2-Oxo-quinolin-1-yl-methyl-phenylacetic acid derivatives as angiotensin II Antagonists |
| 08/03/1994 | CN1090289A Calcium channel blocking polypeptides from theraphosidae aphonopelma |
| 08/03/1994 | CN1090279A Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses |
| 08/03/1994 | CN1090176A Pharmaceutical against renal syndrome |
| 08/02/1994 | US5334767 Benzo[F]quinolinones |
| 08/02/1994 | US5334716 Preventing testosteron 5a-reductase mediated diseases; alopecia, acne, prostatism |
| 08/02/1994 | US5334617 Preventing food spoilage and animal protein aging |
| 08/02/1994 | CA1331132C Method of treatment for non-specific inflammation |
| 07/29/1994 | WO1994017069A1 Pyrazole derivatives and pharmaceutical compositions thereof |
| 07/29/1994 | CA2151930A1 Pyrazole derivatives and pharmaceutical compositions thereof |
| 07/27/1994 | EP0607353A1 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 07/27/1994 | EP0607344A1 3,4-dihydro-4-oxo-3-(prop-2-enyl)-1-phtalazineacetic acids and derivatives, preparations thereof and drugs containing same |
| 07/27/1994 | CN1089950A Derivatives of structurally modified vip and pharmaceutical compositions containing them |
| 07/26/1994 | US5332831 Angiotensin antagonist |
| 07/26/1994 | US5332741 Thiochroman compounds |
| 07/21/1994 | WO1994015966A1 Growth differentiation factor-9 |
| 07/21/1994 | WO1994015956A1 Endothelin converting enzyme inhibitors |
| 07/21/1994 | WO1994015934A1 Quinoline-3-acetic acid derivative, process for producing the same, and use thereof |
| 07/21/1994 | WO1994015916A1 Selective ligands of receptors 5-ht1d-5ht1b derived from indole-piperazine useful as medicaments |
| 07/21/1994 | WO1994015641A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
| 07/21/1994 | WO1994015630A1 Chemotactic factors for human spermatozoa and their use in human assisted fertilization |
| 07/21/1994 | WO1994015606A1 Olefin-substituted long chain compounds |
| 07/21/1994 | WO1994012170A3 Polyunsaturated fatty acid based drugs, in particular docosahexaenoic acid, for use as platelet aggregation inhibitors and against essential fatty acid deficiencies of the brain |
| 07/21/1994 | CA2153776A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |